RT Journal Article
SR Electronic
T1 Oxygen therapy for infants with chronic lung disease
JF Archives of Disease in Childhood - Fetal and Neonatal Edition
JO Arch Dis Child Fetal Neonatal Ed
FD BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health
SP F11
OP F14
DO 10.1136/fn.87.1.F11
VO 87
IS 1
A1 S Kotecha
A1 J Allen
YR 2002
UL http://fn.bmj.com/content/87/1/F11.abstract
AB Supplemental oxygen is a safe and effective treatment for infants with established chronic lung disease who are not at risk of further progression of retinopathy of prematurity (ROP). Oxygen saturations of < 92% should be avoided and a target range of at least 94–96% aimed for. The saturation target range for very preterm infants at risk of developing ROP is more controversial, but the therapeutic index is probably considerably narrower.